J&J names Joaquin Duato as CEO effective January 3, replacing Alex Gorsky
Joaquin Duato, executive vice president and worldwide chairman of pharmaceuticals at Johnson & Johnson on Tuesday, Jan. 31, 2017.
Andrew Harrer | Bloomberg | Getty Images
Johnson & Johnson announced Thursday evening that Joaquin Duato will become the company’s new CEO effective January 3, replacing current chairman and CEO Alex Gorsky.
Duato will be appointed as a member of the company’s Board of Directors following his transition to CEO.
“It has been an honor and privilege to lead this company as Chairman and CEO for nearly a decade, and I am pleased to serve as Executive Chairman to help oversee Johnson & Johnson’s ongoing progress improving the health of people and communities everywhere,” the company wrote in a statement.
Vials labelled “COVID-19 Coronavirus Vaccine” and syringe are seen in front of displayed Johnson & Johnson logo in this illustration taken, February 9, 2021.
Dado Ruvic | Reuters
This is breaking news. Please check back for updates.